Hutchmed (China)
HCM
Enerpac Tool
EPAC
Ermenegildo Zegna NV
ZGN
Lantheus
LNTH
eBay
EBAY
US Stock MarketDetailed Quotes
IART Integra Lifesciences
- 24.720
- +2.670+12.11%
Close Feb 25 16:00 ET
- 25.400
- +0.680+2.75%
Pre 04:08 ET
1.91BMarket Cap-274.67P/E (TTM)
25.450High21.250Low1.91MVolume21.500Open22.050Pre Close46.93MTurnover2.89%Turnover RatioLossP/E (Static)77.22MShares37.17052wk High1.24P/B1.63BFloat Cap16.80552wk Low--Dividend TTM66.10MShs Float77.400Historical High--Div YieldTTM19.05%Amplitude1.500Historical Low24.549Avg Price1Lot Size
Integra Lifesciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.47%1.61B | 11.49%442.65M | -0.41%380.83M | 9.68%418.18M | -3.14%368.87M | -1.03%1.54B | -0.25%397.04M | -0.72%382.42M | -4.16%381.27M | 1.12%380.85M |
| Operating revenue | 4.47%1.61B | 11.49%442.65M | -0.41%380.83M | 9.68%418.18M | -3.14%368.87M | -1.03%1.54B | -0.25%397.04M | -0.72%382.42M | -4.16%381.27M | 1.12%380.85M |
| Cost of revenue | 10.90%728.47M | 13.50%193.57M | 10.07%180.6M | 10.34%192.26M | 9.50%162.04M | 11.83%656.84M | 15.28%170.55M | 10.53%164.08M | 17.41%174.24M | 3.79%147.98M |
| Gross profit | -0.30%882.06M | 9.97%249.07M | -8.29%200.24M | 9.12%225.92M | -11.18%206.83M | -8.82%884.74M | -9.43%226.49M | -7.77%218.35M | -16.99%207.03M | -0.51%232.87M |
| Operating expense | 10.40%853.65M | 12.08%213.45M | 8.68%208.39M | 17.70%228.95M | 3.25%202.87M | 5.72%773.21M | 4.50%190.45M | 11.68%191.75M | 2.63%194.52M | 4.57%196.49M |
| Selling and administrative expenses | 9.19%716.98M | 9.44%178.52M | 9.41%177.19M | 18.53%195.47M | -0.52%165.8M | 6.54%656.64M | 7.38%163.13M | 12.60%161.95M | 2.65%164.91M | 4.21%166.66M |
| Research and development costs | 10.73%115.38M | 28.52%31.21M | 3.15%27.44M | 11.96%29.77M | 0.90%26.97M | 2.96%104.19M | -9.33%24.28M | 7.52%26.6M | 3.90%26.59M | 10.96%26.72M |
| Depreciation amortization depletion | 72.03%21.29M | 22.45%3.72M | 17.21%3.76M | 22.50%3.71M | 225.19%10.11M | -10.85%12.38M | -14.37%3.03M | 2.13%3.21M | -8.41%3.03M | -20.18%3.11M |
| -Depreciation and amortization | 72.03%21.29M | 22.45%3.72M | 17.21%3.76M | 22.50%3.71M | 225.19%10.11M | -10.85%12.38M | -14.37%3.03M | 2.13%3.21M | -8.41%3.03M | -20.18%3.11M |
| Operating profit | -74.53%28.41M | -1.17%35.63M | -130.65%-8.15M | -124.22%-3.03M | -89.10%3.96M | -53.32%111.53M | -46.86%36.05M | -59.12%26.59M | -79.11%12.5M | -21.19%36.38M |
| Net non-operating interest income expense | -48.04%-50.59M | -53.13%-14.09M | -69.41%-14.32M | -59.45%-13.59M | -7.39%-8.58M | 9.29%-34.18M | -21.35%-9.2M | 11.42%-8.46M | 17.00%-8.53M | 22.23%-7.99M |
| Non-operating interest income | 16.50%20.04M | 7.56%4.89M | 9.59%5.05M | 28.41%5.06M | 22.72%5.04M | 44.35%17.2M | -14.35%4.55M | 41.15%4.61M | 100.46%3.94M | 198.26%4.11M |
| Non-operating interest expense | 37.48%70.63M | 38.06%18.98M | 48.32%19.37M | 49.64%18.65M | 12.60%13.62M | 3.60%51.38M | 6.65%13.75M | 1.98%13.06M | 1.86%12.46M | 3.82%12.1M |
| Other net income (expense) | 6.08%3.94M | -50.07%1.01M | 348.41%2.11M | 1,027.10%1.44M | -143.92%-610K | -70.61%3.72M | -49.05%2.01M | -85.69%471K | -107.83%-155K | -59.49%1.39M |
| Special income (charges) | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Gain on sale of business | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | 6.08%3.94M | -50.07%1.01M | 348.41%2.11M | 1,027.10%1.44M | -143.92%-610K | -69.03%3.72M | -49.05%2.01M | -82.21%471K | -107.83%-155K | -59.49%1.39M |
| Income before tax | -122.50%-18.24M | -21.89%22.54M | -209.42%-20.36M | -497.10%-15.19M | -117.56%-5.23M | -62.10%81.07M | -55.06%28.86M | -68.35%18.61M | -92.59%3.82M | -24.26%29.78M |
| Income tax | -184.73%-11.29M | -65.58%3.11M | -988.63%-9.67M | -673.06%-2.78M | -135.10%-1.95M | -60.03%13.33M | -19.87%9.02M | -110.00%-888K | -105.30%-360K | -13.44%5.55M |
| Net income | -110.25%-6.94M | -2.01%19.44M | -154.85%-10.7M | -396.41%-12.4M | -113.54%-3.28M | -62.48%67.74M | -62.54%19.83M | -60.94%19.5M | -90.66%4.18M | -26.37%24.23M |
| Net income continuous Operations | -110.25%-6.94M | -2.01%19.44M | -154.85%-10.7M | -396.41%-12.4M | -113.54%-3.28M | -62.48%67.74M | -62.54%19.83M | -60.94%19.5M | -90.66%4.18M | -26.37%24.23M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -110.25%-6.94M | -2.01%19.44M | -154.85%-10.7M | -396.41%-12.4M | -113.54%-3.28M | -62.48%67.74M | -62.54%19.83M | -60.94%19.5M | -90.66%4.18M | -26.37%24.23M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -110.25%-6.94M | -2.01%19.44M | -154.85%-10.7M | -396.41%-12.4M | -113.54%-3.28M | -62.48%67.74M | -62.54%19.83M | -60.94%19.5M | -90.66%4.18M | -26.37%24.23M |
| Basic earnings per share | -110.59%-0.09 | -0.74%0.2519 | -158.33%-0.14 | -420.00%-0.16 | -113.33%-0.04 | -61.01%0.85 | -59.73%0.2537 | -60.00%0.24 | -90.74%0.05 | -23.08%0.3 |
| Diluted earnings per share | -110.71%-0.09 | 0.00%0.25 | -158.33%-0.14 | -420.00%-0.16 | -113.79%-0.04 | -61.11%0.84 | -60.32%0.25 | -60.00%0.24 | -90.74%0.05 | -25.64%0.29 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
